Lawmakers promised cancer patients would be protected from Medicaid cuts. Now CMS says otherwise New work requirements are catastrophic

https://www.statnews.com/2026/06/04/medicaid-work-requirements-final-rule-cancer-patients/ By Gwen NicholsJune 4, 2026 Nichols is a hematologist/oncologist, cancer researcher, and chief medical officer of Blood Cancer United.

Competition for obesity drugs, clinical blind spots, and more news from ADA You’re reading the web edition of STAT’s ADA in 30 Seconds newsletter

https://www.statnews.com/2026/06/07/competition-obesity-drugs-clinical-blind-spots-and-more-ada/ By Elizabeth Cooney and Elaine ChenJune 7, 2026

$2 million gene therapy cures require a financing model Decades of value in a single intervention mean we need a new approach

https://www.statnews.com/2026/06/08/financing-gene-therapies-cures-cost/ By William V. PadulaJune 8, 2026 Padula is a senior scholar at the USC Schaeffer Center for Health Policy & Economics, an associate professor of pharmaceutical and health economics at the USC Mann School of Pharmacy and Pharmaceutical Science, and chief scientific officer of Stage Analytics.

When it’s time to save a limb, novel clinic meets unhoused people where they are Vascular surgery experts at Mass General build on trust to offer seamless services: ‘Send them to us’ By Elizabeth CooneyJune 8, 2026

When it’s time to save a limb, novel clinic meets unhoused people where they are Vascular surgery experts at Mass General build on trust to offer seamless services: ‘Send them to us’ By Elizabeth CooneyJune 8, 2026 https://www.statnews.com/2026/06/08/vascular-care-homeless-amputation-prevention-effort-mass-general/

Combination of pancreatic cancer drugs from Tango, Revolution leads to high response rate Tango plans to move the combo approach to a Phase 3 trial

https://www.statnews.com/2026/06/08/pancreatic-cancer-combination-tango-therapeutics-revolution-medicines-vopimetostat-daraxonrasib/ By Andrew JosephJune 8, 2026 Europe Correspondent

J&J spends $1 billion to enter KRAS race for cancer treatments Acquisition of Firefly Bio follows field-changing Revolution Medicines data

https://www.statnews.com/2026/06/08/johnson-and-johnson-firefly-cancer-kras-treatment/ By Jason MastJune 8, 2026 General Assignment Reporter

AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials Treatment could come with advantages, but similar therapies have seen liver issues

https://www.statnews.com/2026/06/08/astrazeneca-obesity-diabetes-treatment-studies/ By Elaine ChenJune 8, 2026 Chen, a national biotech reporter, is the co-author of The Readout, a newsletter about the business, science, and politics of biotech.